Dicerna to Participate in Upcoming Investor Conferences
February 06 2018 - 7:30AM
Business Wire
Dicerna Pharmaceuticals, Inc. (Nasdaq:DRNA), a leading developer
of investigational ribonucleic acid interference (RNAi)
therapeutics, today announced that Douglas M. Fambrough, Ph.D.,
president and chief executive officer, will participate in two
investor conferences.
- SunTrust Rare Disease Day - Dr.
Fambrough will participate in the SunTrust Robinson Humphrey 2018
Orphan Drug Day on Tuesday, February 13, 2018, at the JW Marriott
Essex House in New York.
- Leerink Global Healthcare Conference –
Dr. Fambrough will participate in a fireside chat on Wednesday,
February 14, 2018 at 1:00 p.m. ET at the Lotte New York Palace in
New York.
A live webcast of the fireside chat at the Leerink Global
Healthcare Conference can be accessed on the Investors & Media
section on the Dicerna website at www.dicerna.com. An archived
replay of the webcast will be available on the Company’s website
after the conference.
About Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company
focused on the discovery and development of innovative,
subcutaneously delivered RNAi-based therapeutics for diseases
involving the liver, including rare diseases, chronic liver
diseases, cardiovascular diseases, and viral infectious diseases.
Dicerna is leveraging its proprietary GalXC™ RNAi technology
platform to build a broad pipeline in these core therapeutic areas,
focusing on target genes where connections between target gene and
diseases are well understood and documented. Dicerna intends to
discover, develop and commercialize novel therapeutics either on
its own or in collaboration with pharmaceutical partners. For more
information, please visit www.dicerna.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180206005171/en/
Investors:Rx Communications GroupPaula Schwartz,
917-322-2216pschwartz@rxir.comorMedia:SmithSolveAlex Van
Rees, 973-442-1555 ext. 111alex.vanrees@smithsolve.com
Dicerna Pharmaceuticals (NASDAQ:DRNA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Dicerna Pharmaceuticals (NASDAQ:DRNA)
Historical Stock Chart
From Apr 2023 to Apr 2024